haloperidol has been researched along with Acute Kidney Injury in 12 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "BACKGROUND Rhabdomyolysis is a condition in which intracellular components are released into the blood and urine." | 5.72 | A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19. ( Hirose, N; Inoue, J; Ishii, J; Koshioka, S; Kunishima, H; Kurata, T; Matsuura, M; Nagumo, F; Sada, Y; Samura, M; Takada, K; Tanikawa, K; Uchida, M, 2022) |
| "This case comes into the so-called neuroleptic malignant syndrome which can rarely arise in patients treated with antipsycotic agents and which causes high mortality, particularly when there are rhabdomyolysis and acute renal failure." | 5.29 | [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)]. ( Benati, F; Cesario, V; Lazzarin, M, 1996) |
| "A patient with bipolar I disorder has been treated with lithium and haloperidol for the last 20 years and received an ACE inhibitor for his hypertension since 9 years ago." | 3.85 | Hypertensive bipolar: chronic lithium toxicity in patients taking ACE inhibitor. ( Abdul Aziz, MF; Masiran, R, 2017) |
| "Neuroleptic malignant syndrome and acute myoglobinuric renal failure developed in three patients after they had received a combination of a major tranquilizer and a tricyclic antidepressant or after a large dose of haloperidol." | 3.66 | Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome. ( Eiser, AR; Neff, MS; Slifkin, RF, 1982) |
| "BACKGROUND Rhabdomyolysis is a condition in which intracellular components are released into the blood and urine." | 1.72 | A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19. ( Hirose, N; Inoue, J; Ishii, J; Koshioka, S; Kunishima, H; Kurata, T; Matsuura, M; Nagumo, F; Sada, Y; Samura, M; Takada, K; Tanikawa, K; Uchida, M, 2022) |
| "It is well known that the myoglobinuric acute renal failure caused by drugs is an important clinical aspect of nephrology." | 1.29 | [Clinical investigation of 10 cases with acute renal failure induced by neuroleptics]. ( Arimura, Y; Fukuoka, K; Ishizuka, S; Karube, M; Kitamoto, K; Minoshima, S; Miyake, N; Nagasawa, T; Nakabayasi, K; Saitou, M; Soejima, A; Suzuki, M; Tanaka, U, 1996) |
| "This case comes into the so-called neuroleptic malignant syndrome which can rarely arise in patients treated with antipsycotic agents and which causes high mortality, particularly when there are rhabdomyolysis and acute renal failure." | 1.29 | [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)]. ( Benati, F; Cesario, V; Lazzarin, M, 1996) |
| "The management of the neuroleptic malignant syndrome and its complications is discussed." | 1.28 | Neuroleptic malignant syndrome with renal and respiratory complications--a case report. ( Liam, CK; Ong, SB, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Takada, K | 1 |
| Sada, Y | 1 |
| Samura, M | 1 |
| Matsuura, M | 1 |
| Hirose, N | 1 |
| Kurata, T | 1 |
| Nagumo, F | 1 |
| Ishii, J | 1 |
| Koshioka, S | 1 |
| Uchida, M | 1 |
| Inoue, J | 1 |
| Tanikawa, K | 1 |
| Kunishima, H | 1 |
| Kajani, R | 1 |
| Apramian, A | 1 |
| Vega, A | 1 |
| Ubhayakar, N | 1 |
| Xu, P | 1 |
| Liu, A | 1 |
| Masiran, R | 1 |
| Abdul Aziz, MF | 1 |
| Eiser, AR | 1 |
| Neff, MS | 1 |
| Slifkin, RF | 1 |
| Soejima, A | 3 |
| Saito, M | 1 |
| Kitamoto, K | 2 |
| Nagasawa, T | 3 |
| Marsh, SJ | 1 |
| Dolson, GM | 1 |
| Korzets, Z | 1 |
| Zelter, E | 1 |
| Bernheim, J | 1 |
| Suzuki, M | 2 |
| Ishizuka, S | 1 |
| Miyake, N | 1 |
| Karube, M | 1 |
| Fukuoka, K | 1 |
| Minoshima, S | 1 |
| Tanaka, U | 1 |
| Arimura, Y | 1 |
| Nakabayasi, K | 1 |
| Saitou, M | 1 |
| Lazzarin, M | 1 |
| Benati, F | 1 |
| Cesario, V | 1 |
| Seki, Y | 1 |
| Takahashi, H | 1 |
| Aizawa, Y | 1 |
| Liam, CK | 1 |
| Ong, SB | 1 |
1 review available for haloperidol and Acute Kidney Injury
| Article | Year |
|---|---|
[Rhabdomyolysis].
Topics: Acute Kidney Injury; Adult; Chlorpromazine; Female; Haloperidol; Humans; Myoglobin; Myoglobinuria; R | 1991 |
11 other studies available for haloperidol and Acute Kidney Injury
| Article | Year |
|---|---|
A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19.
Topics: Acute Kidney Injury; COVID-19; Haloperidol; Hematuria; Humans; Male; Middle Aged; Rhabdomyolysis | 2022 |
Neuroleptic malignant syndrome in a COVID-19 patient.
Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coron | 2020 |
Hypertensive bipolar: chronic lithium toxicity in patients taking ACE inhibitor.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Bipolar Disorder; Delirium; Diagnosis | 2017 |
Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome.
Topics: Acute Kidney Injury; Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Dehydration; Fem | 1982 |
[Autopsy study of malignant syndrome with fatal acute renal failure].
Topics: Acute Kidney Injury; Autonomic Nervous System Diseases; Female; Haloperidol; Humans; Middle Aged; My | 1982 |
Rhabdomyolysis and acute renal failure during high-dose haloperidol therapy.
Topics: Acute Kidney Injury; Adult; Antipsychotic Agents; Haloperidol; Humans; Male; Neuroleptic Malignant S | 1995 |
Acute renal failure in the setting of the neuroleptic malignant syndrome.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Antipsychotic Agents; Dopamine Antagonists; Female; Ha | 1996 |
[Clinical investigation of 10 cases with acute renal failure induced by neuroleptics].
Topics: Acute Kidney Injury; Adult; Antipsychotic Agents; Barbiturates; Benzodiazepines; Female; Haloperidol | 1996 |
[Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)].
Topics: Acute Kidney Injury; Antipsychotic Agents; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malig | 1996 |
[Hemostatic evaluation of a patient with haloperidol-induced neuroleptic malignant syndrome associated with disseminated intravascular coagulation].
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Antipsychotic Agents; Blood Coagulation; Blood Coagula | 1998 |
Neuroleptic malignant syndrome with renal and respiratory complications--a case report.
Topics: Acute Kidney Injury; Antipsychotic Agents; Female; Haloperidol; Humans; Neuroleptic Malignant Syndro | 1990 |